Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

Transforming growth factor-beta 1 (TGF-beta 1) is inhibitory for breast epithelial cells in vitro and treatment of breast cancer cell lines with tamoxifen results in a rise in TGF-beta 1 mRNA expression with associated inhibition of cell growth. To study whether these findings apply in vivo we exami...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, A. M., Kerr, D. J., Steel, C. M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1991
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972347/
https://www.ncbi.nlm.nih.gov/pubmed/2021547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972347/
https://www.ncbi.nlm.nih.gov/pubmed/2021547

Ejemplares similares